DEBORA DOWDA: Open Payments
NPI 1124059365 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 27 payments from 13 companies in 2025. Trend: 2023 $611 · 2024 $793 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| ABBVIE INC. | 5 | $93 |
| Novo Nordisk Inc | 2 | $64 |
| Lilly USA, LLC | 3 | $55 |
| ABIOMED | 1 | $41 |
| Exact Sciences Corporation | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Recor Medical Inc | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Ascensia Diabetes Care Us Inc. | 1 | $16 |
Products named: FARXIGA, AIRSUPRA, Ozempic, QULIPTA, MOUNJARO, UBRELVY, The Cologuard Plus Collection Kit, Auvelity.
Industry payments across TN — which companies pay providers there.
